XML 32 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Operating expenses:    
Research and development $ 6,487 $ 6,689
General and administrative 29,146 4,819
Revaluation of contingent royalty obligation to Evolus Founders, a related party 10,500 0
Depreciation and amortization 9 218
Total operating expenses 46,142 11,726
Loss from operations (46,142) (11,726)
Other income (expense):    
Interest income 203 0
Interest expense (863) (5)
Loss before taxes (46,802) (11,731)
Provision (benefit) for income taxes 65 (7,251)
Net loss (46,867) (4,480)
Comprehensive loss $ (46,867) $ (4,480)
Net loss per share, basic and diluted (in dollars per share) $ (1.92) $ (0.27)
Weighted-average shares outstanding used to compute basic and diluted net loss per share (in shares) 24,402,368 16,527,000